New stem cell research has identified novel therapeutic targets for MS treatment
World | News | 1 Comment | 20 Dec, 2018
The preclinical findings published in Cell Reports reveal that activation of a specific transcription factor induces a p...Read more
Gilead Sciences and Scholar Rock announce strategic collaboration
World | News | 0 Comment | 20 Dec, 2018
Gilead Sciences and Scholar Rock Holding Corporation have announced that the companies have entered into a strategi...Read more
Bayer gets EU nod for Jivi, but to compete ahead: GlobalData
World | News | 0 Comment | 20 Dec, 2018
Pharma major, Bayer has recently received the European Commission approval for its hemophilia A long-acting injectable m...Read more
World | News | 0 Comment | 20 Dec, 2018
Gritstone Oncology, Inc., a clinical-stage biotechnology company developing the next generation of cancer immunotherapie...Read more
Smith to acquire Ceterix for up to $105M
World | News | 0 Comment | 19 Dec, 2018
Singapore - Smith & Nephew announces that it has agreed to acquire Ceterix Orthopaedics and its Novo...Read more
Amgen, Molecular Partners team up for Immuno-Oncology
World | News | 0 Comment | 19 Dec, 2018
Amgen and Molecular Partners, a clinical-stage biotech company pioneering the use of DARPin® therapeutics, have...Read more
Erasca completes $42M series A financing round
World | News | 0 Comment | 19 Dec, 2018
Erasca, a company dedicated to advancing exceptional scientific approaches to erase cancer, has completed a $42 million ...Read more
Lexicon Pharma announces positive topline clinical data for LX9211
World | News | 0 Comment | 19 Dec, 2018
Biopharma company Lexicon Pharmaceuticals, Inc. has announced positive topline results from its Phase 1a study of LX9211...Read more
DelSiTech, Innovare sign licensing agrrement for the development of a long acting HIV Therapy
World | News | 0 Comment | 19 Dec, 2018
DelSiTech Ltd, a Finnish drug delivery technology and drug development company and InnovareR&D, a leading Mexican ph...Read more
IFM Therapeutics announces discovery of new immune system triggers
World | News | 0 Comment | 19 Dec, 2018
IFM Therapeutics (IFM), a privately held biopharmaceutical company focused on developing therapies that modulate novel t...Read more
Staten Biotechnology, Novo Nordisk enter into a deal worth $430M
World | News | 0 Comment | 18 Dec, 2018
Staten Biotechnology has signed a dyslipidaemia licence option deal worth US$430 million with Novo Nordisk. Unde...Read more
Global Cannabis Partnership expands to 31 members
World | News | 0 Comment | 18 Dec, 2018
The Global Cannabis Partnership (GCP) is pleased to announce the addition of seven new Members as it continues to grow i...Read more
Orchard Therapeutics, SIRION Biotech partners for gene therapy
World | News | 0 Comment | 18 Dec, 2018
Orchard Therapeutics, a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patien...Read more
Bristol-Myers Squibb receives positive CHMP Opinion recommending Sprycel for Pediatric Patients
World | News | 0 Comment | 18 Dec, 2018
Bristol-Myers Squibb Company has announced that the Committee for Medicinal Products for Human Use (CHMP) of the Europea...Read more
Bristol-Myers Squibb, Boston Medical Centre announce collaboration
World | News | 0 Comment | 18 Dec, 2018
Bristol-Myers Squibb Company and Boston Medical centre, a private, not-for-profit, academic medical centre has announced...Read more
Merck launches new Steritest NEO Device
World | News | 1 Comment | 18 Dec, 2018
Merck has launched the latest evolution in sterility testing devices, the Steritest™ NEO device, which provides sa...Read more
Lilly to acquire Pre-Clinical Pain Program from Hydra Biosciences
World | News | 0 Comment | 17 Dec, 2018
Eli Lilly and Company has announced an agreement with Hydra Biosciences to acquire all assets related to Hydra's pre-cli...Read more
Lilly announces positive top-line results for Taltz
World | News | 0 Comment | 17 Dec, 2018
Eli Lilly and Company has announced that Taltz® (ixekizumab) met the primary and all major secondary endpo...Read more